Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study

Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sebastian Figueroa-Bonaparte, Jaume Llauger, Sonia Segovia, Izaskun Belmonte, Irene Pedrosa, Elena Montiel, Paula Montesinos, Javier Sánchez-González, Alicia Alonso-Jiménez, Eduard Gallardo, Isabel Illa, Spanish Pompe group, Jordi Díaz-Manera
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/92acffe4ea3d495381a7f63dd8c21825
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:92acffe4ea3d495381a7f63dd8c21825
record_format dspace
spelling oai:doaj.org-article:92acffe4ea3d495381a7f63dd8c218252021-12-02T15:08:37ZQuantitative muscle MRI to follow up late onset Pompe patients: a prospective study10.1038/s41598-018-29170-72045-2322https://doaj.org/article/92acffe4ea3d495381a7f63dd8c218252018-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-29170-7https://doaj.org/toc/2045-2322Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients in clinical practice. In this study, 32 LOPD patients (22 symptomatic and 10 asymptomatic) underwent muscle MRI using 3-point Dixon and were evaluated at the time of the MRI with several motor function tests and patient-reported outcome measures, and again after one year. Muscle MRI showed a significant increase of 1.7% in the fat content of the thigh muscles in symptomatic LOPD patients. In contrast, there were no noteworthy differences between muscle function tests in the same period of time. We did not observe any significant changes either in muscle MRI or in muscle function tests in asymptomatic patients over the year. We conclude that 3-point Dixon muscle MRI is a useful tool for detecting changes in muscle structure in symptomatic LOPD patients and could become part of the current follow-up protocol in daily clinics.Sebastian Figueroa-BonaparteJaume LlaugerSonia SegoviaIzaskun BelmonteIrene PedrosaElena MontielPaula MontesinosJavier Sánchez-GonzálezAlicia Alonso-JiménezEduard GallardoIsabel IllaSpanish Pompe groupJordi Díaz-ManeraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sebastian Figueroa-Bonaparte
Jaume Llauger
Sonia Segovia
Izaskun Belmonte
Irene Pedrosa
Elena Montiel
Paula Montesinos
Javier Sánchez-González
Alicia Alonso-Jiménez
Eduard Gallardo
Isabel Illa
Spanish Pompe group
Jordi Díaz-Manera
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
description Abstract Late onset Pompe disease (LOPD) is a slow, progressive disorder characterized by skeletal and respiratory muscle weakness. Enzyme replacement therapy (ERT) slows down the progression of muscle symptoms. Reliable biomarkers are needed to follow up ERT-treated and asymptomatic LOPD patients in clinical practice. In this study, 32 LOPD patients (22 symptomatic and 10 asymptomatic) underwent muscle MRI using 3-point Dixon and were evaluated at the time of the MRI with several motor function tests and patient-reported outcome measures, and again after one year. Muscle MRI showed a significant increase of 1.7% in the fat content of the thigh muscles in symptomatic LOPD patients. In contrast, there were no noteworthy differences between muscle function tests in the same period of time. We did not observe any significant changes either in muscle MRI or in muscle function tests in asymptomatic patients over the year. We conclude that 3-point Dixon muscle MRI is a useful tool for detecting changes in muscle structure in symptomatic LOPD patients and could become part of the current follow-up protocol in daily clinics.
format article
author Sebastian Figueroa-Bonaparte
Jaume Llauger
Sonia Segovia
Izaskun Belmonte
Irene Pedrosa
Elena Montiel
Paula Montesinos
Javier Sánchez-González
Alicia Alonso-Jiménez
Eduard Gallardo
Isabel Illa
Spanish Pompe group
Jordi Díaz-Manera
author_facet Sebastian Figueroa-Bonaparte
Jaume Llauger
Sonia Segovia
Izaskun Belmonte
Irene Pedrosa
Elena Montiel
Paula Montesinos
Javier Sánchez-González
Alicia Alonso-Jiménez
Eduard Gallardo
Isabel Illa
Spanish Pompe group
Jordi Díaz-Manera
author_sort Sebastian Figueroa-Bonaparte
title Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
title_short Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
title_full Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
title_fullStr Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
title_full_unstemmed Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
title_sort quantitative muscle mri to follow up late onset pompe patients: a prospective study
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/92acffe4ea3d495381a7f63dd8c21825
work_keys_str_mv AT sebastianfigueroabonaparte quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT jaumellauger quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT soniasegovia quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT izaskunbelmonte quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT irenepedrosa quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT elenamontiel quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT paulamontesinos quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT javiersanchezgonzalez quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT aliciaalonsojimenez quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT eduardgallardo quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT isabelilla quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT spanishpompegroup quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
AT jordidiazmanera quantitativemusclemritofollowuplateonsetpompepatientsaprospectivestudy
_version_ 1718388074331766784